MedPath
NMPA Approval

Neostigmine Methylsulfate Injection

国药准字H20243426

April 7, 2024

Drug Information

甲硫酸新斯的明注射液

注射剂

4ml:2mg

化学药品

April 7, 2024

Company Information

Applicant Company

广州高新技术产业开发区科学城揽月路80号科技创新基地D区第6层601-603单元

Manufacturing Company

河北省张家口市宣化县沙岭子镇(东山产业集聚区)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲硫酸新斯的明注射液 - NMPA 批准文号 | MedPath